MedPath

An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients

Phase 3
Completed
Conditions
Early Stage Parkinson's Disease
Interventions
Registration Number
NCT00332917
Lead Sponsor
Solvay Pharmaceuticals
Brief Summary

This is a multicenter, 6 months open label safety extension study for all patients who are willing and eligible to continue from the pivotal, double-blind S308.3.001 trial

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
224
Inclusion Criteria
  • Patients who have completed S308.3.001 trial
Read More
Exclusion Criteria
  • Patients with medically relevant abnormal findings (ECG, physical examination, AEs) at end of the maintenance phase (visit M6, week 24) of study S308.3.001
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Pardoprunox-
Primary Outcome Measures
NameTimeMethod
Safety: laboratory data, adverse events, vital signs, ECG24 weeks
Secondary Outcome Measures
NameTimeMethod
UPDRS parts 1, 2 and 3, CGI-severity, CGI-improvement, PDQ-39 total score: all change from baseline24 weeks

Trial Locations

Locations (130)

Site 281

🇺🇸

Pittsburgh, Pennsylvania, United States

Site 269

🇨🇦

Saskatoon, Canada

Site 208

🇦🇷

Capital Federal, CBA, Argentina

Site 104

🇧🇬

Sofia, Bulgaria

Site 266

🇨🇦

Ottawa, Canada

Site 211

🇨🇱

San Miguel, Chile

Site 212

🇨🇱

Valdivia, Chile

Site 221

🇨🇴

Bogota, Colombia

Site 220

🇨🇴

Medellin, Colombia

Site 121

🇫🇮

Tampere, Finland

Site 124

🇫🇮

Turku, Finland

Site 293

🇺🇸

Gainsville, Florida, United States

Site 206

🇦🇷

Buenos Aires, Argentina

Site 285

🇺🇸

Sunrise, Florida, United States

Site 200

🇦🇷

Buenos Aires, Argentina

Site 202

🇦🇷

Buenos Aires, Argentina

Site 106

🇧🇬

Sofia, Bulgaria

Site 263

🇨🇦

Markham, Canada

Site 261

🇨🇦

Ottawa, Canada

Site 205

🇦🇷

Cordoba, Argentina

Site 268

🇨🇦

Barrie, Canada

Site 265

🇨🇦

Quebec, Canada

Site 210

🇨🇱

Santiago de Chile, Chile

Site 233

🇲🇽

Tlalpan, Mexico

Site 243

🇵🇪

San Isidro-Lima, Peru

Site 274

🇺🇸

Little Rock, Arkansas, United States

Site 278

🇺🇸

Las Vegas, Nevada, United States

Site 270

🇺🇸

Bennington, Vermont, United States

Site 201

🇦🇷

Buenos Aires, Argentina

Site 203

🇦🇷

Ciudad Autonoma de Buenos Aires, Argentina

Site 207

🇦🇷

Ciudad de Buenos Aires, Argentina

Site 100

🇧🇪

Brussels, Belgium

Site 102

🇧🇪

Wilrijk, Belgium

Site 107

🇧🇬

Plovdiv, Bulgaria

Site 224

🇨🇴

Bogota, Colombia

Site 222

🇨🇴

Cali, Colombia

Site 122

🇫🇮

Lappeenranta, Finland

Site 140

🇷🇴

Bucuresti, Romania

Site 252

🇿🇦

Cape Town, South Africa

Site 183

🇺🇦

Kharkiv, Ukraine

Site 184

🇺🇦

Vinnitsa, Ukraine

Site 154

🇷🇺

Moscow, Russian Federation

Site 101

🇧🇪

Genk, Belgium

Site 103

🇧🇬

Sofia, Bulgaria

Site 105

🇧🇬

Sofia, Bulgaria

Site 260

🇨🇦

Calgary, Canada

Site 264

🇨🇦

Greenfield Park, Canada

Site 213

🇨🇱

Providencia, Chile

Site 120

🇫🇮

Oulun yliopisto, Finland

Site 191

🇳🇿

Christchurch, New Zealand

Site 162

🇷🇸

Belgrade, Serbia

Site 250

🇿🇦

Cape Town, South Africa

Site 262

🇨🇦

Quebec, Canada

Site 267

🇨🇦

Toronto, Canada

Site 193

🇮🇳

Mumbai, India

Site 130

🇮🇱

Tel Aviv, Israel

Site 159

🇷🇺

St Petersburg, Russian Federation

Site 160

🇷🇸

Belgrade, Serbia

Site 161

🇷🇸

Belgrade, Serbia

Site 163

🇷🇸

Nis, Serbia

Site 151

🇷🇺

Moscow, Russian Federation

Site 196

🇮🇳

Bangalore, India

Site 174

🇸🇰

Levice, Slovakia

Site 150

🇷🇺

Moscow, Russian Federation

Site 155

🇷🇺

Smolensk, Russian Federation

Site 153

🇷🇺

Yaroslav, Russian Federation

Site 231

🇲🇽

Monterrey N.L., Mexico

Site 190

🇳🇿

Wellington South, New Zealand

Site 244

🇵🇪

Barrios Altos-Lima, Peru

Site 241

🇵🇪

La Victoria-Lima, Peru

Site 271

🇺🇸

San Francisco, California, United States

Site 289

🇺🇸

Charlotte, North Carolina, United States

Site 286

🇺🇸

Rochester, New York, United States

Site 275

🇺🇸

Traverse City, Michigan, United States

Site 287

🇺🇸

St. Louis, Missouri, United States

Site 284

🇺🇸

Huntsville, Alabama, United States

Site 223

🇨🇴

Bogota, Colombia

Site 277

🇺🇸

La Jolla, California, United States

Site 290

🇺🇸

Chicago, Illinois, United States

Site 273

🇺🇸

Tampa, Florida, United States

Site 292

🇺🇸

Bingham Farms, Michigan, United States

Site 283

🇺🇸

Fountain Valley, California, United States

Site 294

🇺🇸

Toledo, Ohio, United States

Site 279

🇺🇸

Ft Lauderdale, Florida, United States

Site 276

🇺🇸

St. Louis, Missouri, United States

Site 291

🇺🇸

Warwick, Rhode Island, United States

Site 272

🇺🇸

Houston, Texas, United States

Site 204

🇦🇷

Buenos Aires, Argentina

Site 282

🇺🇸

Port Charlotte, Florida, United States

Site 280

🇺🇸

Kansas City, Kansas, United States

Site 288

🇺🇸

Ashville, North Carolina, United States

Site 111

🇭🇷

Rijeka, Croatia

Site 113

🇭🇷

Zagreb, Croatia

Site 197

🇮🇳

Visakhapatnam, India

Site 112

🇭🇷

Split, Croatia

Site 110

🇭🇷

Zagreb, Croatia

Site 114

🇭🇷

Zagreb, Croatia

Site 123

🇫🇮

Kuopio, Finland

Site 194

🇮🇳

Hyderabaad, India

Site 198

🇮🇳

Thiruvananthapuram, India

Site 131

🇮🇱

Haifa, Israel

Site 132

🇮🇱

Petach-Tikva, Israel

Site 232

🇲🇽

Aguascalientes, Mexico

Site 230

🇲🇽

Guadalajara - Jalisco, Mexico

Site 240

🇵🇪

Lima, Peru

Site 242

🇵🇪

Surco-Lima, Peru

Site 141

🇷🇴

Craiova, Romania

Site 142

🇷🇴

Mures, Romania

Site 156

🇷🇺

Moscow, Russian Federation

Site 143

🇷🇴

Brasov, Romania

Site 152

🇷🇺

St. Petersburg, Russian Federation

Site 157

🇷🇺

St. Petersburg, Russian Federation

Site 126

🇸🇪

Norrkoping, Sweden

Site 172

🇸🇰

Zilina, Slovakia

Site 251

🇿🇦

Durban, South Africa

Site 253

🇿🇦

Gauteng, South Africa

Site 254

🇿🇦

Pretoria, South Africa

Site 170

🇸🇰

Bratislava, Slovakia

Site 171

🇸🇰

Bratislava, Slovakia

Site 127

🇸🇪

Goteborg, Sweden

Site 173

🇸🇰

Nitra, Slovakia

Site 182

🇺🇦

Kyiv, Ukraine

Site 125

🇸🇪

Stockholm, Sweden

Site 180

🇺🇦

Kharkiv, Ukraine

Site 181

🇺🇦

Kyiv, Ukraine

Site 185

🇺🇦

Lviv, Ukraine

Site 195

🇮🇳

Mumbai, India

Site 199

🇮🇳

New Delhi, India

Site 133

🇮🇱

Ramat-Gan, Israel

Site 158

🇷🇺

Kazan, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath